Skip to content

Music for Insomnia

Better Night - Better Day: a Randomized Controlled Trial of Listening to Music for Improving Insomnia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02321826
Enrollment
57
Registered
2014-12-22
Start date
2015-04-30
Completion date
2017-09-29
Last updated
2017-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia, Sleep Disorders

Brief summary

The aim of this study is to determine the effect of listening to music on sleep quality (subjective and objective), daytime dysfunction and neurophysiological arousal in patients with insomnia.

Detailed description

Sleep problems are highly prevalent in modern society and poor sleep is associated with impaired physical and mental health with large costs for both individuals and society. Pharmacological treatment is recommended only for short-term use, and there is a need to study promising drug-free aids to improve sleep. Furthermore, the mechanisms of insomnia are not well understood. In the present project we will investigate if listening to music can improve sleep quality in persons suffering from insomnia. We will use a randomized controlled trial design including both subjective and objective measures of sleep.

Interventions

BEHAVIORALMusic

Participants choice among 4 genres of music matched on music characteristics

BEHAVIORALAudiobook

Participants choice among 4 types of audiobooks

Sponsors

Aarhus University Hospital
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Insomnia diagnosis

Exclusion criteria

* Use of hypnotic medications * Alcohol or substance abuse * Pregnant or breastfeeding women * Sleep apnea with an apnea hypopnea index (AHI) \>15 * Clinically significant restless leg syndrome or periodic limp movement disorder (PLMS\>25)

Design outcomes

Primary

MeasureTime frameDescription
Change in insomnia severityBaseline and three-weeks follow-upMeasured with the Insomnia Severity Index (ISI)
Change in subjective sleep qualityBaseline and three-weeks follow-upMeasured with the Pittsburgh Sleep Quality Index (PSQI)

Secondary

MeasureTime frameDescription
Change in objective sleep quality (actigraphy)Baseline and three-weeks follow-upTotal sleep time, Sleep efficiency, sleep onset latency and wake after sleep onset as measured with actigraphy
Change in objective sleep quality (PSG)Baseline and three-weeks follow-upTotal sleep time, Sleep efficiency, sleep onset latency and wake after sleep onset as measured with polysomnography
Change in daytime dysfunctionBaseline and three-weeks follow-upMeasured with the Fatigue severity scale (FSS), Becks Depression inventory (BDI-II), State-Trait Anxiety Inventory (STAI) and WHOQOL-BREF
Change in physiological arousalBaseline and three-weeks follow-upMeasured with ECG and respiration rate

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026